Skip to Contents

Meet Us at ADA 2025

Meet Us at ADA 2025.

Metabolic Adaptation of Liver with Treatment of HM15275, a Long-Acting GLP-1/GIP/Glucagon Triple Agonist, Supporting Lean Mass Preservation
Poster Number
755-P
Session
General Poster Session, Jun 22 at 12:30~13:30 PM
Presenter
Hosun Lee /
Hanmi Pharmaceutical
Robust Anti-obesity Effect and Mechanistic Insights of HM15275, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in Animal Model of Obesity
Poster Number
774-P
Session
General Poster Session, Jun 22 at 12:30~13:30 PM
Presenter
Sang Hyun Park, Ph.D /
Hanmi Pharmaceutical
A Novel CRFR2-Selective UCN2 Analog, HM17321, Improves Glycemic Control across Multiple Preclinical Models
Poster Number
842-P
Session
General Poster Session, Jun 22 at 12:30~13:30 PM
Presenter
Seon Myeong Lee /
Hanmi Pharmaceutical
A Novel CRFR2 Selective UCN2 Analog, HM17321, Facilitates Weight Loss and Improves Body Composition across Animal Models of Obesity
Poster Number
843-P
Session
General Poster Session, Jun 22 at 12:30~13:30 PM
Presenter
Seon Myeong Lee /
Hanmi Pharmaceutical
A Novel UCN2 Analog HM17321 with HM15275 Improves Body Composition in Mouse Model of Obesity
Poster Number
886-P
Session
General Poster Session, Jun 22 at 12:30~13:30 PM
Presenter
Hyunjoo Kwon, Ph.D /
Hanmi Pharmaceutical
Safety, Tolerability, and Pharmacokinetics of HM15275, a Novel GLP-1, GIP, and Glucagon Triple Receptor Agonist - Preliminary Results from a Phase 1 Study
Poster Number
1980-LB
Session
Late Breaking Poster Session, Jun 22 at 12:30~13:30 PM
Presenter
Marcus Hompesch, MD /
ProSciento, Inc.

Hanmi's New Story

Creativity, Innovation, and Challenge
A New Era Takes Off at Hanmi

Focus on Making
Innovative Medicines

Hanmi Pharmaceutical is leading innovation in the
pharmaceutical industry with a sustainable R&D
infrastructure covering various therapeutic areas.

Obesity/Metabolism

Developing best-in-class drugs for obesity,
non-alcoholic steatohepatitis,
and more with multiple mechanisms of action

View More

ESG Report

Hanmi ESG is Everyday-life Innovation

View More

Your dream is our future.
Hanmi awaits you.

Join Us